Warsaw, Poland

Malgorzata Krupa

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2011.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Malgorzata Krupa: Innovator in Pharmaceutical Chemistry

Introduction

Malgorzata Krupa is a distinguished inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of compounds that have potential therapeutic applications. Her innovative work has led to the development of valuable substances that can aid in medical treatments.

Latest Patents

Malgorzata Krupa holds a patent for the "Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds." This patent discloses a process for preparing 24-alkyl analogs of cholecalciferol, which are important for the synthesis of pharmacologically active substances. The invention also introduces new intermediates and non-racemic compounds that serve as valuable synthones in pharmaceutical applications.

Career Highlights

Malgorzata is affiliated with the Instytut Farmaceutyczny, where she has been instrumental in advancing research in her field. Her work has not only contributed to the scientific community but has also paved the way for new therapeutic options in medicine.

Collaborations

Throughout her career, Malgorzata has collaborated with notable colleagues, including Andrzej Kutner and Jacek Martynow. These partnerships have enhanced her research and expanded the impact of her innovations in pharmaceutical chemistry.

Conclusion

Malgorzata Krupa's contributions to the field of pharmaceutical chemistry exemplify her dedication to innovation and research. Her patent on cholecalciferol analogs highlights her role as a key inventor in developing new therapeutic compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…